openPR Logo
Press release

Dermatophytosis Treatment Market 2025 | Sun Pharmaceutical Industries Limited, Tinea Pharmaceuticals, NB Therapeutics, Inc., AmDerma Pharmaceuticals, LLC, Valeant Pharmaceuticals International, Inc.

05-08-2019 08:15 AM CET | Health & Medicine

Press release from: TMR Research

Dermatophytosis Treatment Market 2025 | Sun Pharmaceutical

Global Dermatophytosis Treatment Market: Snapshot

Dermatophytosis is an infectious disease caused by fungi known as dermatophytes. This fungus belong to a family of organisms that can break down the keratin in epidermis, nails, horns and hooves, epidermis, and nails. Mostly thriving in soil and involved in soil decomposition, these fungi can infect living hosts as well.

Get Brochure of the Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=16

Dermatophytosis treatment has unique features. Firstly, the disease is present only on the skin’s keratin and it feeds on keratin for nutrition. However, the presence of the fungus on the skin and its metabolic products causes an allergic reaction in the host. It can affect a host of body parts. This includes the scalp, groin, feet, bearded skin of the face, and the nails. The symptom of Dermatophytosis vary from mild inflammations to severe vesicular reactions.

Dermatophytosis develops either through direct contact with infected wounds or indirectly through infected towels, shoes, or shower stalls. The combination of slight hot weather and tight clothing is conducive for the fungus to thrive.

Topical antifungal creams such as clotrimazole, miconazole, and terbinafine are effective for treating simple forms of Dermatophytosis that is located in parts other than the scalp. The treatment involves cleansing the affected region and rubbing cream on the skin thoroughly.

If the nature of the disease is serious it requires a prescribed line of treatment. This includes prescription drugs along with home care to prevent the infection from spreading. Home care includes avoiding clothing that discomforts the infected area, clean and dry the skin regularly, and wash beddings and clothes daily until the infection is completely clear.

Global Dermatophytosis Treatment Market: Overview

Dermatophytosis is a fungal infection of the skin caused by a fungi that feeds on keratin, a material found in the outer layer of the skin, nails, and hair. Dermatophytosis is commonly referred to as ringworm and affects both humans and animals.

Common symptoms of dermatophytosis include itching, redness, and dryness of the infected area, separation of the nail from the nail bed, scaling, nail dystrophy, broken hair, hair loss, rashes, and nail discoloration. People with weak immune systems and those who play contact sports are at a higher risk of dermatophytosis. The skin condition is known to worsen during the summer with increased symptoms during the winters.

Global Dermatophytosis Treatment Market: Segmentation

On the basis of diagnosis, the global dermatophytosis treatment market is classified into woods test, microscopic test, culture test, and others. By way of drugs used, the market is segmented into Imidazole, Econazole, Clotrimazole, Miconazole, Ketoconazole, Terbinafine, Clotrimazole, Corticosteroid, Terbinafine, Itraconazole, Griseofulvin, and others. Geographically, the dermatophytosis treatment market is segmented as North America, Europe, Asia Pacific, and the Rest of the World (RoW).

Dermatophytosis Treatment Market: Drivers and Restraints

One of the key factors driving the need for dermatophytosis treatment is an increasing population of people with weak immune systems. The immune system weakens with age and a globally rising geriatric population contributing to the high prevalence of dermatophytosis. Apart from this, rising sedentary lifestyle and increasing incidence of hospital-acquired diseases have resulted in a higher rate of dermatophytosis. This has driven the demand for dermatophytosis treatment.

On the other hand, the lack of awareness about dermatophytosis and related diseases, and its treatment options limits the growth prospects of this market. In addition, reluctance on the part of patients in receiving dermatophytosis treatment is restraining the growth of the market globally.

Global Dermatophytosis Treatment Market: Geographical Assessment

From a geographical standpoint, North America presently dominates the global dermatophytosis treatment market, with Europe coming in second. Favorable reimbursement coverage, the availability of immensely developed healthcare infrastructure, a high rate of awareness regarding dermatophytosis, greater healthcare spending, the availability of advanced healthcare facilities, and increased awareness about the benefits of early diagnosis and treatment of dermatophytosis are some of the major factors driving the North America and Europe markets for dermatophytosis treatment.

Asia Pacific possesses high growth potential in the global dermatophytosis treatment market and is likely to witness strong progress in the near future. A rapidly rising literacy rate, improving healthcare infrastructure, a rise in government support to improve healthcare facilities, and growing healthcare spending are some of the key drivers in the Asia Pacific region. The dermatophytosis treatment market in India and China is expected to grow swiftly owing to rapidly developing medical tourism in these countries. Japan is also expected to contribute to the expansion of the dermatophytosis treatment market in Asia with increased focus of the government to offer improved and advanced healthcare facilities to its citizens.

Get TOC for Detailed Facts and Numbers @ https://www.tmrresearch.com/sample/sample?flag=T&rep_id=16

Brazil, Mexico, and Argentina are some of the key countries in the Rest of the World (RoW) segment expected to demonstrate promising growth in the dermatophytosis treatment market.

Global Dermatophytosis Treatment Market: Key Contributors

There are a number of players operating in the global dermatophytosis treatment market. These include Novartis AG, Quinnova Pharmaceuticals, Inc., Sun Pharmaceutical Industries Limited, Tinea Pharmaceuticals, NB Therapeutics, Inc., AmDerma Pharmaceuticals, LLC, Valeant Pharmaceuticals International, Inc., Merz Pharma GmbH & Co. KgaA, Perrigo Company plc. In addition to these, there are several research institutes and universities collaborating with drug manufacturing companies for conducting clinical trials to develop effective dermatophytosis treatment methods.

Some of the key contributors are the University of Minnesota, Karolinska Institute, Katholieke Universiteit Leuven, Eastern Virginia Medical School, Kurdistan University of Medical Sciences, the Department of Health, South Africa, Jamaica Hospital Medical Center, the University of Alabama at Birmingham, The Children’s Mercy Hospital, and Oita University.

About TMR Research

TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Contact:

TMR Research,
3739 Balboa St # 1097,
San Francisco, CA 94121
United States
Tel: +1-415-520-1050

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Dermatophytosis Treatment Market 2025 | Sun Pharmaceutical Industries Limited, Tinea Pharmaceuticals, NB Therapeutics, Inc., AmDerma Pharmaceuticals, LLC, Valeant Pharmaceuticals International, Inc. here

News-ID: 1730727 • Views: 854

More Releases from TMR Research

What more factors have influence over the growth of the global healthcare educat …
Expanding significance of education in the healthcare business to address hierarchical difficulties and convey improved consideration has prompted the merger of healthcare, innovation and advanced arrangement suppliers to create healthcare education solutions. Suppliers of healthcare education solutions are occupied with conveying individual e-learning and consistence solutions to enable associations to accomplish their objectives by defeating difficulties of representative correspondence in an opportune and most advantageous way. Get Sample Copy of this
High Cost of Deployment to Impede Penetration of Back-end Revenue Cycle Manageme …
It’s important to take time to make lasting improvement, not just put a band-aid on for a quick fix. The time-consuming work includes setting goals for performance improvement initiatives, education of staff, regular meetings, performance discussions, and attention to detail on all aspects of the revenue cycle. Partnering with an outsource firm that has expertise in best practices for back-end revenue cycle functions means a lot of that hard work
Healthcare Laboratory Informatics Market Current Trends and Future Aspect Analys …
Health data technology has improved key regions of healthcare like research, academia, and practice. Tech is one of the prime divisions in healthcare that is set to improve the general provider patient experience. The eventual fate of healthcare is focusing at improving patient fulfillment, nature of care, and practice strategies. Laboratory Information Systems (LIS) is a key component of the pathology department or diagnostic. This has led to the formation
Infection Prevention Products and Services : Cantel Medical, Getinge, Steris, Ha …
Governments across the globe are investing highly improving the conditions and facilities in the healthcare sector. To the provide patients will advanced facilities and to further protect them from nosocomial infections the need infection prevention products and services have incased largely. As hospitalized patients are prone to get affected by organism present in the surrounding due to their weak immune system. The products and services used to prevent infection include

All 5 Releases


More Releases for Dermatophytosis

Global Dermatophytosis Drugs Market Insights, Forecast to 2025
Market Research Report Store offers a latest published report on Dermatophytosis Drugs Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 158 pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability. Click to view the full report TOC, figure and tables: https://www.marketresearchreportstore.com/reports/817741/global-dermatophytosis-drugs-market-insights   Ringworm on the skin like athlete's foot (tinea pedis)
Dermatophytosis Treatment Market 2017-2025 | Novartis AG, Quinnova Pharmaceutica …
Global Dermatophytosis Treatment Market: Snapshot Dermatophytosis is an infectious disease caused by fungi known as dermatophytes. This fungus belong to a family of organisms that can break down the keratin in epidermis, nails, horns and hooves, epidermis, and nails. Mostly thriving in soil and involved in soil decomposition, these fungi can infect living hosts as well. Get Brochure of the Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=16 Dermatophytosis treatment has unique features. Firstly, the disease is present
Dermatophytosis Treatment Market - Prime trends of technology 2025 | Novartis AG
Global Dermatophytosis Market: Snapshot Dermatophytosis is an infectious disease caused by fungi known as dermatophytes. This fungus belong to a family of organisms that can break down the keratin in epidermis, nails, horns and hooves, epidermis, and nails. Mostly thriving in soil and involved in soil decomposition, these fungi can infect living hosts as well. Dermatophytosis has unique features. Firstly, the disease is present only on the skin’s keratin and it feeds
Dermatophytosis Treatment Market Key Contributors demonstrate promising growth 2 …
Global Dermatophytosis Market: Snapshot Dermatophytosis is an infectious disease caused by fungi known as dermatophytes. This fungus belong to a family of organisms that can break down the keratin in epidermis, nails, horns and hooves, epidermis, and nails. Mostly thriving in soil and involved in soil decomposition, these fungi can infect living hosts as well. Request Sample Copy of the Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=16 Dermatophytosis has unique features. Firstly, the disease is present
Dermatophytosis Treatment Market Empirical assessment 2025
Global Dermatophytosis Market: Snapshot Dermatophytosis is an infectious disease caused by fungi known as dermatophytes. This fungus belong to a family of organisms that can break down the keratin in epidermis, nails, horns and hooves, epidermis, and nails. Mostly thriving in soil and involved in soil decomposition, these fungi can infect living hosts as well. Dermatophytosis has unique features. Firstly, the disease is present only on the skin’s keratin and it feeds
Dermatophytosis Treatment Market Forecast and Value Chain by 2025
Global Dermatophytosis Market: Snapshot Dermatophytosis is an infectious disease caused by fungi known as dermatophytes. This fungus belong to a family of organisms that can break down the keratin in epidermis, nails, horns and hooves, epidermis, and nails. Mostly thriving in soil and involved in soil decomposition, these fungi can infect living hosts as well. Dermatophytosis has unique features. Firstly, the disease is present only on the skin’s keratin and it feeds